Cancer stem cells in progression of colorectal cancer

Yujuan Zhou; Longzheng Xia; Heran Wang; Linda Oyang; Min Su; Qiang Liu; Jingguan Lin; Shiming Tan; Yutong Tian; Qianjin Liao; Deliang Cao

doi:10.18632/oncotarget.23607

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Cancer stem cells in progression of colorectal cancer

Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao and Deliang Cao _

PDF | HTML | How to cite

Oncotarget. 2018; 9:33403-33415. https://doi.org/10.18632/oncotarget.23607

Metrics: PDF 3567 views | HTML 5668 views | ?

Abstract

Yujuan Zhou1,*, Longzheng Xia1,*, Heran Wang1, Linda Oyang1, Min Su1, Qiang Liu1, Jingguan Lin1, Shiming Tan1, Yutong Tian1, Qianjin Liao1 and Deliang Cao1,2

1Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China

2Department of Medical Microbiology, Immunology & Cell Biology, Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL, 62794, USA

*These authors contributed equally to this work

Correspondence to:

Deliang Cao, email: [email protected]

Qianjin Liao, email: [email protected]

Keywords: colorectal cancer; cancer stem cells; metastasis; epithelial mesenchymal transition; tumor microenvironment

Received: August 28, 2017 Accepted: November 05, 2017 Epub: December 22, 2017 Published: September 07, 2018

ABSTRACT

Colorectal cancer is one of the most common cancers worldwide with high mortality. Distant metastasis and relapse are major causes of patient death. Cancer stem cells (CSCs) play a critical role in the metastasis and relapse of colorectal cancer. CSCs are a subpopulation of cancer cells with unique properties of self-renewal, infinite division and multi-directional differentiation potential. Colorectal CSCs are defined with a group of cell surface markers, such as CD44, CD133, CD24, EpCAM, LGR5 and ALDH. They are highly tumorigenic, chemoresistant and radioresistant and thus are critical in the metastasis and recurrence of colorectal cancer and disease-free survival. This review article updates the colorectal CSCs with a focus on their role in tumor initiation, progression, drug resistance and tumor relapse.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23607

Publication Alerts

Reviews:

Cancer stem cells in progression of colorectal cancer

Abstract